lubiprostone has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, DP; Stengel, JZ | 1 |
| Bindslev, N; Hansen, MB; Kaltoft, N; Osbak, PS; Poulsen, SS; Tilotta, MC; Witte, AB | 1 |
1 trial(s) available for lubiprostone and Colorectal Neoplasms
| Article | Year |
|---|---|
Single-dose lubiprostone along with split-dose PEG solution without dietary restrictions for bowel cleansing prior to colonoscopy: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Alprostadil; Cathartics; Chi-Square Distribution; Colonoscopy; Colorectal Neoplasms; Double-Blind Method; Female; Humans; Lubiprostone; Male; Middle Aged; Placebos; Polyethylene Glycols; Prospective Studies; Solutions | 2008 |
1 other study(ies) available for lubiprostone and Colorectal Neoplasms
| Article | Year |
|---|---|
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
Topics: Alprostadil; Biopsy; Bumetanide; Colforsin; Colon; Colorectal Neoplasms; Dinoprostone; Female; Humans; Ion Transport; Lubiprostone; Male; Middle Aged; Ouabain; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Reference Values; Signal Transduction; Tamoxifen; Theophylline | 2010 |